Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of Lenalidomide in Combination With Vorinostat in Pediatric Patients With High Grade or Progressive Central Nervous System Tumors

NCT03050450 is registered in ClinicalTrials.gov with Johns Hopkins All Children's Hospital as lead sponsor.

NCT NCT03050450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03050450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of Lenalidomide in Combination With Vorinostat in Pediatric Patients With High Grade or Progressive Central Nervous System Tumors
Lead sponsor
Johns Hopkins All Children's Hospital
Phase
Phase 1
Overall status
Terminated
Start date
August 10, 2016
Completion date
December 19, 2018
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central nervous system tumors